Drug
Peginterferon Alfa 2A 180 G
Peginterferon Alfa 2A 180 G: highest development phase Phase 3, developed by Chugai. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Chugai
Trials
| Drug | Phase | Indication |
|---|---|---|
| peginterferon alfa-2a 180μg NCT00304551 | Phase 3 | Liver Cirrhosis |
Latest
No recent events.
Follow Peginterferon Alfa 2A 180 G on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.